Lucerastat Completed Phase 1 Trials for Fabry's Disease Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 1 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT02930655 | A Study to Assess the Safety and Tolerability of Lucerastat in Subjects With Fabry Disease |